000220.KS
Yuyu Pharma, Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 3,805.00
−1.93%Margins
Gross margin
38.2%
EBITDA margin
6.6%
EBIT margin
9.1%
Net margin
8.7%
FCF margin
4.0%
9.3%
Return on equity
6.0%
Return on assets
8.1%
Return on invested capital
0.70x
Asset turnover
KRW 20.9B
Cash from operations
KRW 1.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026